Equities

CureVac NV

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CVACN:MEX

CureVac NV

Actions
  • Price (MXN)76.50
  • Today's Change0.00 / 0.00%
  • Shares traded9.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Dec 29 2025 11:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Qube Research & Technologies Ltd.as of 30 Sep 20251.71m0.00%
BlackRock Fund Advisorsas of 31 Dec 20251.63m0.00%
AQR Arbitrage LLCas of 30 Sep 2025991.69k0.00%
Water Island Capital LLCas of 30 Sep 2025762.14k0.00%
Magnetar Financial LLCas of 30 Sep 2025654.80k0.00%
RBC Dominion Securities, Inc. (Investment Management)as of 30 Sep 2025500.60k0.00%
Bank of America, NA (Private Banking)as of 30 Sep 2025421.04k0.00%
Aperio Group LLCas of 31 Dec 2025325.76k0.00%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 2025312.68k0.00%
CSS LLCas of 30 Sep 2025273.50k0.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.